title: Vaccination of pregnant cows with EspA, EspB, γ-intimin, and Shiga toxin 2 proteins from Escherichia coli O157:H7 induces high levels of specific colostral antibodies that are transferred to newborn calves.
abstract: Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a major cause of intestinal disease and hemolytic uremic syndrome, a serious systemic complication that particularly affects children. Cattle are primary reservoirs for EHEC O157:H7 and the main source of infection for humans. Vaccination of cattle with different combinations of bacterial virulence factors has shown efficacy in decreasing EHEC O157:H7 shedding. It is, therefore, important to demonstrate whether vaccination of pregnant cows with EHEC O157:H7 induces high titers of transferable antibodies to avoid early colonization of calves by the bacteria. In this study we evaluated the ability of EspA, EspB, the C-terminal fragment of 280 amino acids of γ-intimin (γ-intimin C₂₈₀) and inactivated Shiga toxin (Stx) 2 proteins to induce specific antibodies in colostrum and their passive transference to colostrum-fed calves. Friesian pregnant cows immunized by the intramuscular route mounted significantly high serum and colostrum IgG responses against EspB and γ-intimin C₂₈₀ that were efficiently transferred to their calves. Antibodies to EspB and γ-intimin C₂₈₀ were detected in milk samples of vaccinated cows at d 40 postparturition. Significant Stx2-neutralizing titers were also observed in colostrum from Stx2-vaccinated cows and sera from colostrum-fed calves. The results presented showed that bovine colostrum with increased levels of antibodies against EHEC O157:H7 may be obtained by systemic immunization of pregnant cows, and that these specific antibodies are efficiently transferred to newborn calves by feeding colostrum. Hyperimmune colostrum and milk may be an alternative to protect calves from early colonization by EHEC O157:H7 and a possible key source of antibodies to block colonization and toxic activity of this bacterium.
authors.affiliation: Instituto de Patobiología, Instituto Nacional de Tecnología Agropecuaria-INTA, Nicolás Repetto y De los Reseros, 1686 Hurlingham, Buenos Aires, Argentina.
authors.forename: B C
authors.initials: BC
authors.lastname: Rabinovitz
authors.forename: E
authors.initials: E
authors.lastname: Gerhardt
authors.forename: C
authors.initials: C
authors.lastname: Tironi Farinati
authors.forename: A
authors.initials: A
authors.lastname: Abdala
authors.forename: R
authors.initials: R
authors.lastname: Galarza
authors.forename: D A
authors.initials: DA
authors.lastname: Vilte
authors.forename: C
authors.initials: C
authors.lastname: Ibarra
authors.forename: A
authors.initials: A
authors.lastname: Cataldi
authors.forename: E C
authors.initials: EC
authors.lastname: Mercado
mesh_terms: D018829:Adhesins, Bacterial / Q000276:immunology / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn / Q000276:immunology; D000907:Antibodies, Bacterial / Q000276:immunology*; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology / Q000494:pharmacology*; D002417:Cattle / Q000276:immunology*; D003126:Colostrum / Q000276:immunology*; D019453:Escherichia coli O157 / Q000276:immunology*; D029968:Escherichia coli Proteins / Q000276:immunology / Q000494:pharmacology*; D005260:Female; D007112:Immunity, Maternally-Acquired / Q000276:immunology*; D011247:Pregnancy; D022641:Shiga Toxin 2 / Q000276:immunology / Q000494:pharmacology*; D014611:Vaccination / Q000662:veterinary*
chemical_list: D018829:Adhesins, Bacterial; D000907:Antibodies, Bacterial; D001425:Bacterial Outer Membrane Proteins; C087863:EaeB protein, E coli; D029968:Escherichia coli Proteins; C102051:EspA protein, E coli; D022641:Shiga Toxin 2; C073819:eaeA protein, E coli